Image
20.04.2022
"My hope for the future of diabetes care" - Paul Niven
Paul Niven, who lives with type 1 diabetes, attended our professional conference as a guest blogger. He s...
customer support
customer support
From research findings supporting SGLT-2 inhibitors as a first-choice type 2 treatment to a real-world study strengthening evidence for teplizumab in early type 1, here are some of the diabetes research developments announced in February 2026.
Read more